The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, ...

More than 15.5 million U.S. adults have been diagnosed with ADHD, and nearly three-quarters of those taking medication to ...

Your critical medication is out of stock — indefinitely. For a growing number of Americans, this nightmare scenario is ...

The Food and Drug Administration is working to address the shortage of three drugs after a major manufacturer was ...

A new CDC report reveals that over 15.5 million U.S. adults have ADHD, with 71.5 per cent facing difficulties obtaining ...

Investigating America’s Drug Shortage Crisis,” a series exploring the causes and possible solutions of a problem plaguing ...

A report from Sandoz emphasizes the need for collaboration among stakeholders to eliminate drug shortages impacting over 90% ...

Climate change could drive up demand for drugs to treat asthma, kidney disease and Alzheimer's and add to supply chain ...

Federal health officials have approved the import of certain IV fluids from overseas as hospitals across the country scramble ...

Some healthccare facilities in ENC are cutting back on IV treatments due to Hurricane Helene damage at the facility of a ...

A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...